Patents by Inventor Jorge Daniel Erusalimsky

Jorge Daniel Erusalimsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Inhibitors of the Renin-Angiotensin System
    Publication number: 20140045907
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Applicant: FinVector Vision Therapies Ltd
    Inventors: Hugh Edward MONTGOMERY, John Francis Martin, Jorge Daniel Erusalimsky
  • Use of inhibitors of the renin-angiotensin system
    Patent number: 8604070
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: December 10, 2013
    Assignee: FinVector Vision Therapies, Ltd.
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Use Of Inhibitors Of The Renin-Angiotensin System
    Publication number: 20120178784
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Application
    Filed: January 30, 2012
    Publication date: July 12, 2012
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Use of inhibitors of the renin-angiotensin system
    Patent number: 8003679
    Abstract: Inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia, such as stroke.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: August 23, 2011
    Assignee: ArkTherapeutics Group, plc
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Use of inhibitors of the renin-angiotensin system
    Patent number: 7998953
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: August 16, 2011
    Assignee: Ark Therapeutics Group, p.l.c.
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Use of Inhibitors of the Renin-Angiotensin System
    Publication number: 20090069348
    Abstract: It has been found that an inhibitor of the renin-angiotensin system is useful for the treatment or prevention of a condition associated with hypoxia or impaired metabolic function or efficiency. In particular, it may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and is thus useful in treatment of the symptoms and signs of ageing. It may also be used to enhance function in healthy subjects.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 12, 2009
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Use of inhibitors of the renin-angiotensin system
    Patent number: 7071183
    Abstract: It has been found that inhibitors of the renin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: July 4, 2006
    Assignee: Ark Therapeutics Limited
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Use of inhibitors of the renin-angiotensin system
    Publication number: 20050192326
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Application
    Filed: April 29, 2005
    Publication date: September 1, 2005
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Use of inhibitors of the renin-angiotensin system
    Publication number: 20020187939
    Abstract: It has been found that inhibitors of the renin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Application
    Filed: July 26, 2002
    Publication date: December 12, 2002
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky